Streetbeat News

Products Services

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides daily trade strategies for SPY, QQQ, AAPL, MSFT, TSLA, GOOGL, NVDA, and META based on a proprietary formula considering price, volume, and options flow. The memo outlines potential support and resistance levels for each asset and advises traders to be prepared for breakouts or reversals. The release of PCE and GDP data in the premarket session is expected to influence the market. The memo is part of a service offered by Market Clubhouse, which includes a live daily market analysis and real-time mentorship by a professional trader known as RIPS.

Portfolio Pulse from RIPS

November 29, 2023 | 3:29 pm

MSFT

SNPS

Synopsys Inc (NASDAQ:SNPS) is set to report Q4 earnings with expectations of $3.03 EPS and $1.58 billion in revenue. The stock has risen 70% YTD and saw a 2.5%+ increase after announcing a strategic collaboration with Microsoft Inc (NASDAQ:MSFT) involving Synopsys.ai Copilot and Azure OpenAI Service. Analysts focus on Synopsys' AI integration in EDA, demand for AI chips, and internal workflow optimization. The company has a Buy consensus rating with a $405.23 target price, while Stifel's Ruben Roy has a $550 target, citing robust semiconductor design activity and progress on AI tools.

Portfolio Pulse from Surbhi Jain

November 29, 2023 | 3:23 pm

UBER

Uber Technologies, Inc. plans to integrate London's black cabs into its platform in 2024, despite opposition from the Licensed Taxi Drivers Association (LTDA). The service will offer commission-free bookings for the first six months. LTDA criticized Uber's safety record, but Uber cites successful taxi integrations in other cities. The first black cab driver to join Uber sees potential for increased earnings. Uber's Q3 FY23 revenue grew 11% to $9.29 billion, missing estimates, with trips up 25% year-over-year.

Portfolio Pulse from Anusuya Lahiri

November 29, 2023 | 3:23 pm

AMZN

ASML

NVDA

TSM

Nvidia Corp (NVDA) sees its stock rise as it strengthens its partnership with Amazon Web Services (AMZN) for new AI chips and collaborates with Chinese expertise for autonomous vehicles. Nvidia, along with Taiwan Semiconductor Manufacturing Co (TSM), leads the advanced chip market, posing a challenge to competitors like OpenAI. Nvidia dominates the GPU market, crucial for machine learning, while TSMC leads in advanced chip production. Both companies face manufacturing and patent challenges, but Nvidia is adapting its AI chips to comply with U.S. regulations for the China market. NVDA stock has surged over 234% YTD.

Portfolio Pulse from Anusuya Lahiri

November 29, 2023 | 3:19 pm

KRTX

PRTC

Karuna Therapeutics, an entity founded by PureTech Health, announced that the FDA has accepted its New Drug Application for KarXT, aimed at treating schizophrenia. This is a significant step towards the potential approval and commercialization of the drug.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:18 pm

LLY

NVO

Lebanese health officials reported 11 cases of severe hypoglycemia due to suspected counterfeit Ozempic, a diabetes medication by Novo Nordisk (NVO). The fake drugs had incorrect dosages, and the issue is part of a global rise in counterfeit products, with at least 17 countries affected. Novo Nordisk is working with local authorities to address the issue. NVO shares dropped slightly by 0.14%.

Portfolio Pulse from Vandana Singh

November 29, 2023 | 3:17 pm

VVOS

Vivos Therapeutics Inc (NASDAQ:VVOS) received FDA 510(k) clearance for its CARE oral appliances to treat severe obstructive sleep apnea (OSA) in adults. This makes Vivos the first company to offer an alternative to CPAP or surgical neurostimulation implants for severe OSA patients. The approval follows previous clearance for treating mild-to-moderate OSA. Data showed significant improvement in 80% of severe OSA patients with an average treatment time of 9.7 months. VVOS stock surged 169.70% to $11.84.

Portfolio Pulse from Vandana Singh

November 29, 2023 | 3:15 pm

PHG

Philips' stock (NYSE:PHG) is trading lower after the FDA issued a warning about potential overheating of its DreamStation 2 CPAP machines. This follows a June 2021 recall of millions of sleep therapy and respirator machines due to risks from degrading sound-reducing foam. The DreamStation 2, which uses different foam, has had over 270 reports of thermal issues since August 2023. Philips' shares have fallen 3.17% to $20.48.

Portfolio Pulse from Vandana Singh

November 29, 2023 | 3:12 pm

BNGO

Bionano Genomics announced a publication showcasing the use of its Optical Genome Mapping (OGM) technology to evaluate the genome integrity of CRISPR-edited cells, which is crucial for gene therapy development. This development highlights the potential of Bionano's technology in the gene therapy space, which could lead to increased interest and adoption of OGM in research and clinical settings.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:10 pm

CGC

Martha Stewart CBD, in partnership with Marquee Brands LLC and Canopy Growth Corporation (NASDAQ:CGC), has launched a new line of CBD gummies tailored for specific needs. The gummies come in three varieties: Sleep, Chill, and Extra Strength, each with unique flavor profiles and CBD concentrations. Martha Stewart has been an advisor to Canopy since 2019, and despite Sequential Brands filing for bankruptcy in 2021, the collaboration has continued to produce new CBD products.

Portfolio Pulse from Jelena Martinovic

November 29, 2023 | 3:09 pm